
|Videos|June 1, 2023
Efficacy and Safety of Combination Treatments for BCC
Experts in dermatology discuss the efficacy and safety combining hedgehog pathway inhibitors and immunotherapy as treatment for patients with basal cell carcinoma.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times - Dermatology News and Clinical Insights
1
Vitiligo Disease Duration Linked to Depression Severity
2
APG777 May Ease Burden on Patients With AD
3
STRATA Excimer Laser and JAK Inhibitors Delivers Superior Vitiligo Repigmentation
4
Journal Digest: October 8, 2025
5